Glen Harbor Capital Management LLC - ATYR PHARMA INC ownership

Quarter-by-quarter ownership
Glen Harbor Capital Management LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q1 2019$84,000
+10.5%
153,2380.0%0.00%0.0%
Q4 2018$76,000
-39.2%
153,2380.0%0.00%
-33.3%
Q3 2018$125,000
-10.7%
153,2380.0%0.00%0.0%
Q2 2018$140,000
-65.5%
153,2380.0%0.00%
-66.7%
Q1 2018$406,000
-24.3%
153,2380.0%0.01%
-25.0%
Q4 2017$536,000
-30.7%
153,2380.0%0.01%
-33.3%
Q3 2017$774,000
+46.3%
153,2380.0%0.02%
+38.5%
Q2 2017$529,000
-1.3%
153,2380.0%0.01%0.0%
Q1 2017$536,000
+38.9%
153,238
-14.7%
0.01%
+30.0%
Q4 2016$386,000179,7240.01%
Other shareholders
ATYR PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 130,571$670,0000.53%
FEDERATED HERMES, INC. 7,393,715$2,709,0000.01%
VIKING GLOBAL INVESTORS LP 3,209,955$1,176,0000.01%
WEDBUSH SECURITIES INC 67,270$25,0000.00%
Renaissance Technologies 1,845,873$676,0000.00%
BlackRock Inc. 125,916$46,0000.00%
TWO SIGMA SECURITIES, LLC 23,202$9,0000.00%
TWO SIGMA ADVISERS, LP 11,900$4,0000.00%
BREWIN DOLPHIN LTD 6,000$2,1980.00%
ROYAL BANK OF CANADA 17$00.00%
View complete list of ATYR PHARMA INC shareholders